Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort
- PMID: 34022837
- PMCID: PMC8140461
- DOI: 10.1186/s12883-021-02243-3
Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort
Abstract
Background: Ala97Ser transthyretin amyloidosis-associated polyneuropathy (ATTRA97S-PN) is a rare form of inherited polyneuropathy, usually manifesting with late-onset (> 50) progressive polyneuropathy. This mutation is mostly prevalent in Taiwanese and Han-Chinese individuals. The aim of this study was to describe the clinical and comprehensive neurophysiological profiles of ATTRA97S-PN in Thai patients.
Methods: The clinical profiles and serial neurophysiologic studies (nerve conduction study (NCS), quantitative sensory test (QST), and comprehensive autonomic function test (AFT)) of symptomatic ATTRA97S-PN patients who had been followed-up at King Chulalongkorn Memorial Hospital during 2010-2020 were retrospectively reviewed.
Results: Nine symptomatic patients (55.6 % were male) from four unrelated families were included. All were Thais of mixed Thai Chinese descent. The mean age of onset was 48.3 (32-60) years. The mean age at diagnosis was 54.8 (33-66) years. Three patients developed early-onset (< 40y) polyneuropathy. The mean Neuropathy Impairment Score was 41.33 (10-92) at diagnosis. Sensory (9/9) and autonomic (9/9) neuropathies were more frequent than motor neuropathy (5/9), which appeared in the late stage of disease. Hypoesthesia in the feet, and gastrointestinal autonomic symptoms were frequently reported as the initial symptoms. The course of neuropathy progressed over years to decades. The worsening of neuropathy tended to progress faster once motor nerves were affected in both clinical and neurophysiological aspects. Concurrent cardiac amyloidosis was found in 6/9 patients. NCS showed length-dependent sensorimotor axonal polyneuropathy in 5/9 patients, and median neuropathy at the wrist (mostly bilateral) in 7/9 patients. QST showed abnormalities in the vibratory detection threshold, the cold detection threshold and the heat pain sensation in 8/9, 8/9 and 7/7 tested patients, respectively. AFT results were abnormal in all. The mean composite autonomic severity score was 5 (3-9).
Conclusions: This clinical study is the first of ATTRA97S-PN in Thai patients. The mixed polyneuropathy-cardiopathy phenotype was the most common manifestation. In this cohort, the age of onset was lower, and the course of neuropathy was relatively longer, than that in previous studies. Some patients may develop early-onset polyneuropathy. This mutation has not yet been documented in any population other than Han Chinese-related populations, probably suggesting a founder effect. Further studies are warranted.
Keywords: Ala97Ser; Thais; autonomic neuropathy; carpal tunnel syndrome; composite autonomic severity score; hereditary transthyretin amyloidosis-associated polyneuropathy; neurophysiological study; quantitative sensory test; transthyretin.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Similar articles
-
Clinical features of hereditary transthyretin amyloidosis-polyneuropathy with transthyretin Ala97Ser(p.Ala117Ser) mutation in South Mainland China.Orphanet J Rare Dis. 2025 Apr 28;20(1):202. doi: 10.1186/s13023-025-03733-0. Orphanet J Rare Dis. 2025. PMID: 40296002 Free PMC article.
-
Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.Amyloid. 2022 Jun;29(2):92-101. doi: 10.1080/13506129.2021.2014448. Epub 2022 Jan 7. Amyloid. 2022. PMID: 34994254
-
Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis.Brain Behav. 2017 Dec 19;8(1):e00889. doi: 10.1002/brb3.889. eCollection 2018 Jan. Brain Behav. 2017. PMID: 29568686 Free PMC article.
-
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.J Neurol. 2021 Jun;268(6):2109-2122. doi: 10.1007/s00415-019-09688-0. Epub 2020 Jan 6. J Neurol. 2021. PMID: 31907599 Free PMC article. Review.
-
Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management.Can J Neurol Sci. 2022 Jan;49(1):7-18. doi: 10.1017/cjn.2021.34. Epub 2021 Feb 26. Can J Neurol Sci. 2022. PMID: 33631091 Review.
Cited by
-
Clinical features of hereditary transthyretin amyloidosis-polyneuropathy with transthyretin Ala97Ser(p.Ala117Ser) mutation in South Mainland China.Orphanet J Rare Dis. 2025 Apr 28;20(1):202. doi: 10.1186/s13023-025-03733-0. Orphanet J Rare Dis. 2025. PMID: 40296002 Free PMC article.
-
TTR Gly83Arg Mutation: Beyond Familial Vitreous Amyloidosis.Front Neurol. 2022 Feb 3;12:821003. doi: 10.3389/fneur.2021.821003. eCollection 2021. Front Neurol. 2022. PMID: 35185758 Free PMC article.
-
Use of Technetium-99m-Pyrophosphate Single-Photon Emission Computed Tomography/Computed Tomography in Monitoring Therapeutic Changes of Eplontersen in Patients With Hereditary Transthyretin Amyloid Cardiomyopathy.J Am Heart Assoc. 2024 Jan 16;13(2):e030512. doi: 10.1161/JAHA.123.030512. Epub 2024 Jan 12. J Am Heart Assoc. 2024. PMID: 38214277 Free PMC article.
-
Tafamidis improves myocardial longitudinal strain in A97S transthyretin cardiac amyloidosis.Ther Adv Chronic Dis. 2024 Jan 11;15:20406223231222828. doi: 10.1177/20406223231222828. eCollection 2024. Ther Adv Chronic Dis. 2024. PMID: 38223905 Free PMC article.
-
A molecular basis for tetramer destabilization and aggregation of transthyretin Ala97Ser.Protein Sci. 2023 Apr;32(4):e4610. doi: 10.1002/pro.4610. Protein Sci. 2023. PMID: 36851846 Free PMC article.
References
-
- Rowczenio D, Wechalekar A. Mutations in hereditary amyloidosis. 2015 http://amyloidosismutations.com/mut-attr.php. Accessed 30 Mar 2021.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials